» Articles » PMID: 15137079

Modeling Mass Transfer in Hepatocyte Spheroids Via Cell Viability, Spheroid Size, and Hepatocellular Functions

Overview
Publisher Wiley
Specialty Biochemistry
Date 2004 May 12
PMID 15137079
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocyte aggregation into spheroids attributes to their increased activity, but in the absence of a vascular network the cells in large spheroids experience mass transfer limitations. Thus, there is a need to define the spheroid size which enables maximal cell viability and productivity. We developed a combined theoretical and experimental approach to define this optimal spheroid size. Hepatocyte spheroids were formed in alginate scaffolds having a pore diameter of 100 microm, in rotating T-flasks or spinners, to yield a maximal size of 100, 200, and 600 microm, respectively. Cell viability was found to decrease with increasing spheroid size. A mathematical model was constructed to describe the relationship between spheroid size and cell viability via the oxygen mass balance equation. This enabled the prediction of oxygen distribution profiles and distribution of viable cells in spheroids with varying size. The model describes that no oxygen limitation will take place in spheroids up to 100 microm in diameter. Spheroid size affected the specific rate of albumin secretion as well; it reached a maximal level, i.e., 60 microg/million cells/day in 100-microm diameter spheroids. This behavior was depicted in an equation relating the specific albumin secretion rate to spheroid size. The calculated results fitted with the experimental data, predicting the need for a critical number of viable hepatocytes to gain a maximal albumin secretion. Taken together, the results on mass transport in spheroids and its effects on cell viability and productivity provide a useful tool for the design of 3D scaffolds with pore diameters of 100 microm.

Citing Articles

Proposal for a non-adhesive single-cell culture technology for primary hepatocytes.

Uehara M, Bual R, Shafiq M, Yoshida K, Ijima H Cytotechnology. 2025; 77(1):30.

PMID: 39744312 PMC: 11685352. DOI: 10.1007/s10616-024-00696-1.


CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays.

Cho Y, Laird M, Bishop T, Li R, Jazwinska D, Ruffo E APL Bioeng. 2024; 8(3):036105.

PMID: 39049849 PMC: 11268919. DOI: 10.1063/5.0207941.


A Review on Patient-derived 3D Micro Cancer Approach for Drug Screen in Personalized Cancer Medicine.

Sekeroglu Z, Sekeroglu V Curr Cancer Drug Targets. 2024; 25(2):118-130.

PMID: 38445692 DOI: 10.2174/0115680096285910240206044830.


Sacrificial-Rotating Rod-Based 3D Bioprinting Technique for the Development of an In Vitro Cardiovascular Model.

Lee J, Lee H J Funct Biomater. 2024; 15(1).

PMID: 38276475 PMC: 10817312. DOI: 10.3390/jfb15010002.


Design Optimization Method for Large-Size Sidewall-Driven Micromixer to Generate Powerful Swirling Flow.

Yamamoto D, Takayama T Micromachines (Basel). 2023; 14(12).

PMID: 38138415 PMC: 10745643. DOI: 10.3390/mi14122246.